The amount of immunoglobulin G antibodies in the blood is associated with a person's likelihood of being protected against adverse cardiac events, according to data from the ASCOT trial reported in EBioMedicine . In this specific hypertensive ... Healio, 7 hours ago
Statins Plus CYP3A4 Inhibitors Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are widely prescribed, and widely recognized to carry a high risk for drug/drug interactions. Owing to differences in elimination pathways, ...Dermatology Online Journal, 10 hours ago
By John Vandermosten, CFA We are initiating coverage of Resverlogix Corp. (RVX.TO) with a CAD$5.00 price target based on our estimates of a 2020 launch of RVX-208 (apabetalone) in Europe and Latin America, followed by a launch in the United States ...Yahoo! Finance, 10 hours ago
India's largest drugmaker Sun Pharmaceutical Industries is banking on the launch of newer and more complex products to offset rising competition in its lucrative U.S. dermatology business, its U.S. chief said. The world's fifth-largest maker of generic drugs ...Sify, 1 week ago India's Sun Pharma bets on new products to boost U.S. skincare products growth Sify, 1 week ago
on your WebpageAdd Widget >Get your members hooked!